HPV Testing and Pap Test Market: Current Progress, Growth Drivers, challenges, and Future Development

[Healthcare News]

HPV Testing and Pap Test is growing rapidly as an industry due to development of new cervical cancer diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the HPV testing and Pap test market.

Currently, HPV Testing and Pap Test Market is growing at a Compound Annual Growth Rate (CAGR) of 13.2% to reach USD 9.2 billion by 2027. Market growth is driven by the increased focus of government on cervical cancer and increasing initiatives to spread the awareness on cervical cancer prevention.

Request for assumptions & how numbers were triangulated.

https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371 

Market Growth Drivers

• Advancements in NGS platforms
• Declining costs of genome sequencing
• Improving regulatory and reimbursements scenario for NGS based diagnostics lab
• Growing incidence of cancer and increasing applications of NGS in cancer research

Market Growth Opportunities

• Regulatory guidelines for cervical cancer screening
• Innovative improvements in HPV tests

Market Challenges 

• Uncertain reimbursement scenario
• Stringent regulatory & legal requirements
• Operational barriers

Restraints

• Growing awareness of HPV vaccination

The prominent players operating in the HPV Testing and Pap Test Market are Abbott Laboratories (US), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US), Hologic, Inc. (US), Quest Diagnostics (US), Qiagen N.V. (Netherland), Seegene, Inc. (US)

In 2021, Abbott Laboratories (US) held the leading position in the HPV testing and Pap test market. The company has maintained a leading position in the market through its strong presence across North America. He company also adopts organic growth strategies to increase its dominance in this market by innovating new products to increase the product range. The company has a wide distribution network spread across over 150 countries and 291 subsidiaries.

In 2021, Roche Diagnostics (Switzerland) held the second position in the HPV testing and Pap test market. It has an increased presence in North America, Europe and the Asia Pacific with a strong network and growth strategies. Roche focuses on increasing R&D with increased investment for innovation. The company has strong presence in North America and its major share comes from US.

Download an Illustrative Overview:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371 

Competitive leadership mapping has been updated considering recent developments in the company evaluation matrix and company profiles section of the current edition of the market report.

Largest Share Segments

• HPV testing segment accounted for the largest share of the HPV testing and Pap test market, by test type.
• HPV testing segment accounted for the largest share of the HPV testing and Pap test market, by application.
• Hospitals segment accounted for the largest share of the HPV testing and Pap test market, by end user.

Content Source: 

https://www.prnewswire.com/news-releases/hpv-testing-and-pap-test-m...

https://www.digitaljournal.com/pr/hpv-testing-and-pap-test-market-w...

https://www.prnewswire.co.uk/news-releases/hpv-testing-and-pap-test...